|
US5958901A
(en)
*
|
1995-06-07 |
1999-09-28 |
Genta Incorporated |
Phosphonic acid-based cationic lipids
|
|
US20030073640A1
(en)
*
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
|
EP1724254A3
(en)
*
|
1997-07-23 |
2012-01-04 |
Sirna Therapeutics, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
|
US6281371B1
(en)
|
1997-08-13 |
2001-08-28 |
Biontex Laboratories Gmbh |
Lipopolyamines, and the preparation and use thereof
|
|
US7915238B2
(en)
*
|
1999-02-01 |
2011-03-29 |
Eisai R & D Management Co., Ltd. |
Immunomodulatory compounds and methods of use thereof
|
|
US6835721B2
(en)
|
1999-02-01 |
2004-12-28 |
Eisai Co., Ltd. |
Immunomodulatory compounds and methods of use thereof
|
|
US20040006242A1
(en)
|
1999-02-01 |
2004-01-08 |
Hawkins Lynn D. |
Immunomodulatory compounds and method of use thereof
|
|
US6551600B2
(en)
*
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
WO2001037883A1
(en)
*
|
1999-11-24 |
2001-05-31 |
University Of Oregon |
Complexes of alkylphosphonic acids
|
|
CN101041079A
(zh)
*
|
1999-12-30 |
2007-09-26 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
|
US6686461B1
(en)
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
|
CA2391316A1
(en)
*
|
2000-03-22 |
2001-09-27 |
Solulink, Incorporated |
Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
|
|
US7102024B1
(en)
|
2000-08-01 |
2006-09-05 |
Schwartz David A |
Functional biopolymer modification reagents and uses thereof
|
|
JP2002071941A
(ja)
*
|
2000-08-25 |
2002-03-12 |
Kureha Chem Ind Co Ltd |
光学材料
|
|
DE10117043A1
(de)
*
|
2001-04-05 |
2002-11-07 |
Gerhard Puetz |
Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
|
|
JP2005508396A
(ja)
*
|
2001-11-02 |
2005-03-31 |
イントラディグム、コーポレイション |
核酸送達ビヒクルのための治療方法
|
|
US7901708B2
(en)
|
2002-06-28 |
2011-03-08 |
Protiva Biotherapeutics, Inc. |
Liposomal apparatus and manufacturing methods
|
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
|
US7158353B2
(en)
*
|
2003-11-06 |
2007-01-02 |
Seagate Technology Llc |
Magnetoresistive sensor having specular sidewall layers
|
|
US7799565B2
(en)
|
2004-06-07 |
2010-09-21 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering RNA
|
|
CA2587411A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Protiva Biotherapeutics, Inc. |
Sirna silencing of apolipoprotein b
|
|
EP1874342B1
(en)
|
2005-04-26 |
2018-06-06 |
Eisai R&D Management Co., Ltd. |
Compositions and methods for cancer immunotherapy
|
|
US20070292418A1
(en)
*
|
2005-04-26 |
2007-12-20 |
Eisai Co., Ltd. |
Compositions and methods for immunotherapy
|
|
US20070087045A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Industrial Technology Research Institute |
Lipid carrier and method of preparing the same
|
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
|
WO2009082817A1
(en)
*
|
2007-12-27 |
2009-07-09 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
|
WO2009086558A1
(en)
*
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
AU2009238175C1
(en)
|
2008-04-15 |
2023-11-30 |
Arbutus Biopharma Corporation |
Novel lipid formulations for nucleic acid delivery
|
|
CN104119242B
(zh)
|
2008-10-09 |
2017-07-07 |
泰米拉制药公司 |
改善的氨基脂质和递送核酸的方法
|
|
CA2750561C
(en)
|
2009-01-26 |
2017-10-10 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein c-iii expression
|
|
WO2010107487A2
(en)
*
|
2009-03-18 |
2010-09-23 |
Wu Nian |
Lipid-drug conjugates for drug delivery
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
ES2613498T3
(es)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
|
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
|
US8455455B1
(en)
|
2010-03-31 |
2013-06-04 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes involved in hemorrhagic fever
|
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
WO2014070687A2
(en)
*
|
2012-10-29 |
2014-05-08 |
Molecular Transfer, Inc. |
Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
|
|
JP5914418B2
(ja)
|
2013-06-26 |
2016-05-11 |
富士フイルム株式会社 |
脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
|
|
WO2018209130A1
(en)
|
2017-05-11 |
2018-11-15 |
Tc1 Llc |
Thermal interconnect for implantable blood pump
|
|
CA3101484A1
(en)
*
|
2018-05-30 |
2019-12-05 |
Translate Bio, Inc. |
Phosphoester cationic lipids
|
|
IL303195A
(en)
|
2020-11-25 |
2023-07-01 |
Akagera Medicines Inc |
Lipid nanoparticles for delivery of nucleic acids and related methods of use
|
|
EP4531819A2
(en)
|
2022-05-25 |
2025-04-09 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|